Literature DB >> 8110321

Use of anti-D in an accident and emergency department.

A M Huggon1, D P Watson.   

Abstract

A retrospective study was made of the use of anti-D in an accident and emergency (A&E) department in 1 month. Patients who are discharged home with a diagnosis of threatened miscarriage should have their blood group determined and anti-D should be given to those who are rhesus negative. We found that only 8/29 patients discharged from the department had their blood group determined and none of the rhesus negative patients was given anti-D. We have introduced a practical method of reminding medical staff to give anti-D to patients who require it.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8110321      PMCID: PMC1286038          DOI: 10.1136/emj.10.4.306

Source DB:  PubMed          Journal:  Arch Emerg Med        ISSN: 0264-4924


  3 in total

1.  Deaths from Rh haemolytic disease in England and Wales in 1988 and 1989.

Authors:  R M Hussey; C A Clarke
Journal:  BMJ       Date:  1991-08-24

2.  Immunoprophylaxis for rhesus disease--expensive but worth it?

Authors:  M Selinger
Journal:  Br J Obstet Gynaecol       Date:  1991-06

3.  Underutilization of Rh prophylaxis in the emergency department: a retrospective survey.

Authors:  J Grant; M Hyslop
Journal:  Ann Emerg Med       Date:  1992-02       Impact factor: 5.721

  3 in total
  3 in total

1.  Management of bleeding in early pregnancy in accident and emergency departments.

Authors:  C Gilling-Smith; P Toozs-Hobson; D J Potts; R Touquet; R W Beard
Journal:  BMJ       Date:  1994-09-03

2.  Use of anti-D immunoglobulin in the treatment of threatened miscarriage in the accident and emergency department.

Authors:  L Weinberg
Journal:  Emerg Med J       Date:  2001-11       Impact factor: 2.740

Review 3.  Appropriate provision of anti-D prophylaxis to RhD negative pregnant women: a scoping review.

Authors:  Trina M Fyfe; M Jane Ritchey; Christorina Taruc; Daniel Crompton; Brian Galliford; Rose Perrin
Journal:  BMC Pregnancy Childbirth       Date:  2014-12-10       Impact factor: 3.007

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.